指南与共识肝肾功能剂量调整治疗药物监测与药物基因组学

持续低效透析中药物剂量推荐的范围综述

Scoping review of drug dosing recommendations in sustained low-efficiency dialysis.
指南 / 共识 · Pharmacotherapy · 2024-12-19

本范围综述旨在回答「持续低效透析(SLED)中药物剂量已有何种文献描述」。研究间透析液流速、透析时长和药物剂量差异很大,结局和药代动力学参数异质,SLED中药物剂量证据极少,建议有条件时对所有SLED患者进行治疗药物监测。

要点

  • SLED中药物剂量证据极少,仅29项研究涉及四类药物。
  • 各研究透析液流速、透析时长和剂量差异大,药代参数异质。
  • 有条件时应对所有SLED患者进行治疗药物监测。

核心结论

  • SLED中药物剂量具有挑战性,现有证据极少,不足以指导合理剂量。
  • 需要更大规模研究以准确确定SLED中药物剂量。
  • 有条件时应对所有SLED患者进行治疗药物监测。

研究设计与样本

  • 范围综述,遵循Arksey和O'Malley框架及PRISMA-ScR指南。
  • 共筛选230条文献,全文审查后纳入29项研究。
  • 排除病例报告、会议摘要、儿科、治疗性透析和非人类受试者。
  • 由两名研究者独立筛选文献并使用混合方法评价工具评估证据质量。

主要发现

  • 纳入研究涉及四类药物:β-内酰胺类抗生素、非β-内酰胺类抗生素、抗真菌药和左乙拉西坦。
  • 各研究间透析液流速、透析时长和药物剂量差异很大。
  • 所评估的结局和药代动力学参数也存在异质性。

临床怎么用

  • SLED患者用药时应认识到现有剂量推荐证据有限。
  • 有条件时应对所有SLED患者进行治疗药物监测。

局限性

  • 现有证据极少,研究间异质性大,难以汇总剂量推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The objective of this scoping review was to answer the question, "What has been published describing drug dosing in sustained low-efficiency dialysis (SLED)?" PubMed, Embase, and Scopus were searched on November 18, 2022. Methodology followed the Arksey and O'Malley framework for scoping reviews and Preferred Reporting Items for Systematic Reviews and Meta-Analysis Extension for Scoping Reviews guidelines. Two investigators independently screened abstracts and full-texts of citations identified related to drug dosing and SLED. Exclusion criteria included case reports, conference abstracts, pediatrics, treatment dialysis, and non-human subjects. A standardized data extraction sheet was used to collate and summarize data. The quality of evidence was evaluated by two investigators using the Mixed Methods Appraisal Tool. A total of 230 citations were identified for screening. Of these, 29 studies met criteria for inclusion after full-text review. Four drug groups including beta-lactam antibiotics, non-beta-lactam antibiotics, antifungals, and levetiracetam were identified. Dialysate rates, dialysis durations, and medication doses used varied widely across studies. Outcomes and pharmacokinetic parameters that were assessed were also heterogenous. Drug dosing in SLED is challenging and there is minimal evidence available to guide appropriate dosing. Larger studies are needed to more accurately determine how to appropriately dose medications in SLED. Therapeutic drug monitoring should be used in all patients on SLED when available.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Nelson NR, Quinn NJ, Bills S, et al. Scoping review of drug dosing recommendations in sustained low-efficiency dialysis. Pharmacotherapy. 2024. PMID: 39702906. doi:10.1002/phar.4628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。